合并慢性病与代偿期及失代偿期肝硬化患者生存:一项基于人群的研究
这项基于人群的研究纳入35361例肝硬化患者,采用含时依协变量的Cox比例风险模型,评估糖尿病、慢性肾脏病和心血管病对死亡率的个体及叠加影响。合并慢性病数量越多,校正后死亡风险越高;代偿期肝硬化合并3种慢性病者的生存率与部分失代偿期肝硬化患者相近。作者认为应重视合并慢性病管理并早期开展多学科照护。
要点
- 合并慢性病数量越多,肝硬化患者校正后死亡风险逐级升高。
- 代偿期肝硬化合并3种慢性病者生存率与部分失代偿期患者相近。
- 作者提出应重视合并慢性病这一潜在管理目标并早期多学科照护。
核心结论
- 在肝硬化患者中,关注合并慢性病作为潜在管理目标可能有助于避免过早死亡,且与病因无关;除现有门静脉高压并发症管理外,肝硬化临床早期即需要多学科照护。
研究设计与样本
- 基于人群研究,使用含时依协变量的Cox比例风险模型,评估合并慢性病(糖尿病、慢性肾脏病、心血管病)对肝硬化患者死亡率的影响。
- 共纳入35361例肝硬化患者,平均年龄59.5岁,女性41.8%,非白人29.7%,西班牙裔17.5%。
主要发现
- 合并慢性病情况:1种病28.9%,2种病17.5%,3种病12.6%,多数患者有心血管病(45%)。
- 校正后死亡风险随慢性病数量增加而升高:1种病HR 2.5(95%CI 2.23-2.8),2种病HR 3.27(95%CI 2.9-3.69),3种病HR 4.52(95%CI 3.99-5.12)。
- 代偿期肝硬化合并3种慢性病者生存率为67.7%,代偿期肝硬化合并1-3种慢性病者为61.9%-63.9%。
临床怎么用
- 作者认为,关注合并慢性病作为潜在管理目标可能有助于避免过早死亡,且与病因无关。
- 作者提出,除现有门静脉高压并发症管理外,肝硬化临床早期即需要多学科照护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The burden of liver disease is substantial and increasing; the impact of comorbid chronic diseases on the clinical course of patients with compensated and decompensated cirrhosis is not well-defined. The aim of this study was to examine the individual and additive impact of comorbid chronic diseases on mortality in patients with cirrhosis. METHODS: In this population-based study, we used Cox proportional hazards modeling with time-dependent covariates to assess the impact of comorbid chronic diseases (diabetes mellitus, chronic kidney disease, and cardiovascular disease [CVD]) on mortality in patients with cirrhosis in a large, diverse Metroplex. RESULTS: There were 35,361 patients with cirrhosis (mean age 59.5 years, 41.8% females, 29.7% non-White, and 17.5% Hispanic ethnicity). Overall, the presence of chronic comorbidities was 1 disease (28.9%), 2 diseases (17.5%), and 3 diseases (12.6%) with a majority having CVD (45%). Adjusted risk of mortality progressively increased with an increase in chronic diseases from 1 (hazard ratio [HR] 2.5, 95% confidence interval [CI] 2.23-2.8) to 2 (HR 3.27.95% CI 2.9-3.69) to 3 (HR 4.52, 95% CI 3.99-5.12) diseases. Survival of patients with compensated cirrhosis and 3 chronic diseases was similar to subsets of decompensated cirrhosis (67.7% as compared with decompensated cirrhosis with 1-3 conditions, 61.9%-63.9%). DISCUSSION: In patients with cirrhosis, a focus on comorbid chronic disease(s) as potential management targets may help avoid premature mortality, regardless of etiology. Multidisciplinary care early in the clinical course of cirrhosis is needed in addition to the current focus on management of complications of portal hypertension.
引用
- Asrani SK, Hall L, Reddy V, et al. Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based Study. Am J Gastroenterol. 2022. PMID: 35849622. doi:10.14309/ajg.0000000000001909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。